The use of SGLT2 inhibitors for 10 weeks improved cardiac function as a result of enhancing autophagy by reducing the expression level of miR-30d, which was significantly increased during the development of DCM in this model [219]. Here, SLC5A2 is linked to familial dilated cardiomyopathy.